Studies Paint Nuanced Picture of Insulin Out-of-Pocket Costs

Medicare enrollees this fall will be able to sign up for prescription plans that cap copayments for insulin at $35 a month. A recent Kaiser Family Foundation analysis shows that average annual out-of-pocket spending on insulin among Medicare Part D enrollees without low-income subsidies (LIS) increased from $324 in 2007 to $580 in 2017. Meanwhile, a new study in JAMA Internal Medicine found that insulin accounted for just 18% of all out-of-pocket spending among privately insured patients with type 1 diabetes in 2018 — and accounted for less out-of-pocket spending than diabetes-related supplies.

0

0

0 Comments

0

0

• Radar on Drug Benefits